AAAAAA
Results: 1-25/41
Authors:
Hoque, A
Albanes, D
Lippman, SM
Spitz, MR
Taylor, PR
Klein, EA
Thompson, IM
Goodman, P
Stanford, JL
Crowley, JJ
Coltman, CA
Santella, RM
Citation: A. Hoque et al., Molecular epidemiologic studies within the selenium and vitamin e cancer prevention trial (SELECT), CANC CAUSE, 12(7), 2001, pp. 627-633
Authors:
Kupelian, PA
Reddy, CA
Klein, EA
Willoughby, TR
Citation: Pa. Kupelian et al., Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life, INT J RAD O, 51(4), 2001, pp. 988-993
Authors:
Kupelian, PA
Buchsbaum, JC
Reddy, CA
Klein, EA
Citation: Pa. Kupelian et al., Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason <= 6, and pretreatment prostate-specific antigen <= 10), INT J RAD O, 50(3), 2001, pp. 621-625
Authors:
Wilkinson, DA
Lee, EJ
Ciezki, JP
Mohan, D
Zippe, C
Angermeier, K
Ulchaker, J
Klein, EA
Citation: Da. Wilkinson et al., Dosimetric comparison of pre-planned and or-planned prostate seed brachytherapy (vol 48, pg 1241, 2000), INT J RAD O, 49(1), 2001, pp. 297-297
Authors:
Dreicer, R
See, WA
Klein, EA
Citation: R. Dreicer et al., Phase II trial of GM-CSF in advanced prostate cancer, INV NEW DR, 19(3), 2001, pp. 261-265
Authors:
Dreicer, R
Klein, EA
Citation: R. Dreicer et Ea. Klein, Preliminary observations of single-agent docetaxel as neoadjuvant therapy for locally advanced prostate cancer, SEMIN ONCOL, 28(4), 2001, pp. 45-48
Authors:
Lieberman, R
Nelson, WG
Sakr, WA
Meysken, FL
Klein, EA
Wilding, G
Partin, AW
Lee, JJ
Lippman, SM
Citation: R. Lieberman et al., Executive summary of the National Cancer Institute Workshop: Highlights and recommendations, UROLOGY, 57(4A), 2001, pp. 4-27
Authors:
Klein, EA
Meyskens, FL
Citation: Ea. Klein et Fl. Meyskens, Potential target populations and clinical models for testing chemopreventive agents, UROLOGY, 57(4A), 2001, pp. 171-173
Authors:
Thompson, IM
Kouril, M
Klein, EA
Coltman, CA
Ryan, A
Goodman, P
Citation: Im. Thompson et al., The prostate cancer prevention trial: Current status and lessons learned, UROLOGY, 57(4A), 2001, pp. 230-234
Authors:
Clark, PE
Peereboom, DM
Dreicher, R
Levin, HS
Clark, SB
Klein, EA
Citation: Pe. Clark et al., Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer, UROLOGY, 57(2), 2001, pp. 281-285
Authors:
Klein, EA
Thompson, IM
Lippman, SM
Goodman, PJ
Albanes, D
Taylor, PR
Coltman, C
Citation: Ea. Klein et al., Select: The next prostate cancer prevention trial, J UROL, 166(4), 2001, pp. 1311-1315
Authors:
Hsu, THS
Klein, EA
Citation: Ths. Hsu et Ea. Klein, Subtotal radical cystectomy after radical prostatectomy: A source of pelvic recurrence of bladder cancer with life threatening bleeding, J UROL, 166(3), 2001, pp. 988-989
Authors:
Jahveri, FM
Brawer, MK
Klein, EA
Citation: Fm. Jahveri et al., The role of prostate specific antigen and its variants in prostate cancer screening, CURR CLIN U, 2001, pp. 79-90
Authors:
Klein, EA
Thompson, IM
Lippman, SM
Goodman, PJ
Albanes, D
Taylor, PR
Coltman, C
Citation: Ea. Klein et al., SELECT: the selenium and vitamin E cancer prevention trial: Rationale and design, PROSTATE C, 3(3), 2000, pp. 145-151
Authors:
Wilkinson, DA
Lee, EJ
Ciezki, JP
Mohan, D
Zippe, C
Angermeier, K
Ulchaker, J
Klein, EA
Citation: Da. Wilkinson et al., Dosimetric comparison of pre-planned and OR-planned prostate seed brachytherapy, INT J RAD O, 48(4), 2000, pp. 1241-1244
Authors:
Kupelian, PA
Mohan, DS
Lyons, J
Klein, EA
Reddy, CA
Citation: Pa. Kupelian et al., Higher than standard radiation doses (>= 72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer, INT J RAD O, 46(3), 2000, pp. 567-574
Authors:
Suarez, BK
Lin, J
Witte, JS
Conti, DV
Resnick, MI
Klein, EA
Burmester, JK
Vaske, DA
Banerjee, TK
Catalona, WJ
Citation: Bk. Suarez et al., Replication linkage study for prostate cancer susceptibility genes, PROSTATE, 45(2), 2000, pp. 106-114
Authors:
Chen, HC
Bhattacharyya, N
Wang, LM
Recupero, AJ
Klein, EA
Harter, ML
Banerjee, S
Citation: Hc. Chen et al., Defective DNA repair genes in a primary culture of human renal cell carcinoma, J CANC RES, 126(4), 2000, pp. 185-190
Authors:
Gill, IS
Fergany, A
Klein, EA
Kaouk, JH
Sung, GT
Meraney, AM
Savage, SJ
Ulchaker, JC
Novick, AC
Citation: Is. Gill et al., Laparoscopic radical cystoprostatectomy with ileal conduit performed completely intracorporeally: The initial 2 cases, UROLOGY, 56(1), 2000, pp. 26-29
Authors:
Fergany, A
Kupelian, PA
Levin, HS
Zippe, CD
Reddy, C
Klein, EA
Citation: A. Fergany et al., No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients, UROLOGY, 56(1), 2000, pp. 92-95
Authors:
Sohayda, C
Kupelian, PA
Levin, HS
Klein, EA
Citation: C. Sohayda et al., Extent of extracapsular extension in localized prostate cancer, UROLOGY, 55(3), 2000, pp. 382-386
Authors:
Zippe, CD
Jhaveri, FM
Klein, EA
Kedia, S
Pasqualotto, FF
Kedia, A
Agarwal, A
Montague, DK
Lakin, MM
Citation: Cd. Zippe et al., Role of Viagra after radical prostatectomy, UROLOGY, 55(2), 2000, pp. 241-245
Authors:
Ciezki, JP
Klein, EA
Angermeier, KW
Ulchaker, J
Zippe, CD
Wilkinson, DA
Citation: Jp. Ciezki et al., Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer, UROLOGY, 55(1), 2000, pp. 68-72
Authors:
Lyons, JA
Kupellan, PA
Mohan, DS
Reddy, CA
Klein, EA
Citation: Ja. Lyons et al., Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate, UROLOGY, 55(1), 2000, pp. 85-90
Authors:
Klein, EA
Citation: Ea. Klein, Open technique for nerve-sparing retroperitoneal lymphadenectomy, UROLOGY, 55(1), 2000, pp. 132-135